Growth Metrics

Emergent BioSolutions (EBS) Long-Term Debt Repayments (2017 - 2021)

Historic Long-Term Debt Repayments for Emergent BioSolutions (EBS) over the last 8 years, with Q1 2021 value amounting to $10.6 million.

  • Emergent BioSolutions' Long-Term Debt Repayments changed N/A to $10.6 million in Q1 2021 from the same period last year, while for Dec 2021 it was $10.6 million, marking a year-over-year change of. This contributed to the annual value of $10.6 million for FY2021, which is N/A changed from last year.
  • Emergent BioSolutions' Long-Term Debt Repayments amounted to $10.6 million in Q1 2021.
  • In the past 5 years, Emergent BioSolutions' Long-Term Debt Repayments registered a high of $20.0 million during Q1 2017, and its lowest value of $10.6 million during Q1 2021.